| Literature DB >> 16520854 |
David F Blackburn1, Thomas W Wilson.
Abstract
Increased rates of diabetes have been reported with thiazide diuretics and beta-blockers, but not with angiotensin-converting enzyme inhibitors, angiotensin receptor blockers or calcium channel blockers. These observations are important because significant glycemic effects of drugs may be a source of accelerated cardiovascular risk that is not detectable during restricted clinical trial follow-up periods. The extent to which diabetes is affected by these medications remains unclear, as is the precise mechanism by which diabetes is promoted. However, several plausible theories are presented herein. Although drug-induced diabetes has been a concern for several years, not enough information is available to influence prescribing for the majority of patients. The number one priority should be controlling blood pressure in a timely manner.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16520854 PMCID: PMC2528930 DOI: 10.1016/s0828-282x(06)70902-3
Source DB: PubMed Journal: Can J Cardiol ISSN: 0828-282X Impact factor: 5.223